We report on a multiplexed, ratiometric method that can confidently distinguish between cancerous and non-cancerous epithelial prostate cells in vitro, as demonstrated by a double blind experiment. The technique is based on bright SERRS biotags (SBTs) infused with unique Raman reporter molecules, and carrying cell-specific peptides. Two sets of SERRS biotags were used. One targets the neuropilin-1 (NRP) receptors of cancer cells through the RPARPAR peptide. The other functions as a positive control (PC) and binds to both non-cancerous and cancer cells through the HIV derived TAT peptide. Averaging the SERRS signal over a given cell yielded an NRP/PC ratio from which a robust quantitative measure of the overexpression of the NRP-1 by the cancer cell line was extracted. The use of a local, on-cell reference produces quantitative, statistically robust measures of overexpression independent of such sources of uncertainty such as variations in the location of the focal plane, the local cell concentration and turbidity.